High-Fructose Corn Syrup
HFCS-42 / HFCS-55
The corn-derived liquid sugar in much of the processed-food supply.
Moderate evidence
🍬Sweeteners & Additives
Evidence tier
Moderate
Research weight
Citations
12 verified / 12
Classification
Sweeteners & Additives
❝
What the evidence says. Several controlled trials; effects real but modest or context-dependent.
What is High-Fructose Corn Syrup?
High-Fructose Corn Syrup (HFCS-42 / HFCS-55) is a sweetener or food additive used for high-intensity caloric sweetness (~4 kcal/g) comparable to table sugar. NutriDex grades the human evidence as Moderate. High-fructose corn syrup (HFCS) is a liquid sweetener made from corn starch by enzymatically isomerizing some glucose to fructose, yielding HFCS-42 (~42% fructose, used in baked goods and processed foods) and HFCS-55 (~55% fructose, used in soft drinks). The FDA affirmed it as GRAS in 1996 (21 CFR 184.1866) with no quantitative limit beyond good manufacturing practice, and there is no separate ADI because it is treated as a caloric food, not an additive. Controlled-feeding trials show HFCS behaves metabolically much like sucrose gram-for-gram, with no consistent difference in weight or most cardiometabolic markers. The substantive evidence-based concern is not HFCS specifically but added/free sugars in general — especially sugar-sweetened beverages — which large cohorts and dose-response meta-analyses link to higher risk of type 2 diabetes, cardiovascular disease, and fatty liver.
Purported Benefits
✓High-intensity caloric sweetness (~4 kcal/g) comparable to table sugar
✓Liquid form blends easily and resists crystallization, improving texture and shelf stability
✓Browning/Maillard reactions for baked-good color and flavor
✓Humectant — retains moisture and extends shelf life
✓Lower cost and easier handling than granulated sucrose for manufacturers
✓Glycemic: raises blood glucose and insulin (the fructose fraction is metabolized in the liver, the glucose fraction is fully glycemic)
Dosing & Compounds
Typical Dose
USA: FDA-affirmed GRAS as a direct human food ingredient (21 CFR 184.1866; effective 1996), used per current good manufacturing practice with no numerical limit. No ADI is assigned by FDA, EFSA, or JECFA because HFCS is a nutritive caloric sweetener rather than a food additive. Dietary guidance instead caps total added/free sugars: WHO strongly recommends free sugars below 10% of energy (conditional <5%), and the US Dietary Guidelines recommend <10% of calories from added sugars.
Active Compounds
Safety & Cautions
At equal intakes HFCS is not shown to be uniquely harmful versus table sugar: controlled-feeding meta-analyses find no significant difference in body weight or most metabolic markers, though one pooled analysis found modestly higher CRP (an inflammation marker) with HFCS than sucrose. The real, well-documented risk is excess added sugar in general — particularly from sugar-sweetened beverages — which large prospective cohorts and dose-response meta-analyses associate with higher type 2 diabetes, coronary heart disease, and cardiovascular mortality risk, and with hepatic de novo lipogenesis, raised uric acid, and fatty-liver (MASLD) markers when fructose is consumed in excess. HFCS is not carcinogenic and is safe for the general population in moderation; it is not 'natural' or beneficial. People managing diabetes, obesity, metabolic syndrome, fatty liver, gout/hyperuricemia, or hypertriglyceridemia should limit it, and it is a primary contributor to discretionary calories in children. People with hereditary fructose intolerance must avoid it entirely. Educational only — always check with your doctor or pharmacist before combining High-Fructose Corn Syrup with any medicine.
Key Studies ★ 12 studies
Meta-analysis
Dietary sugar & T2D dose-response meta-analysis 2025
✓ Full text
Dose-response meta-analysis of prospective cohorts (incl. 18 SSB cohorts, n=541,288) found sugar consumed as beverages was associated with higher incident type 2 diabetes risk, whereas added sugar/fructose as isolated nutrients showed no association.
Meta-analysis
Qin 2023 (Frontiers in Nutrition)
✓ Full text
Meta-analysis found sugar-sweetened beverage consumption associated with higher risk of type 2 diabetes, hypertension, cardiovascular disease, and all-cause mortality across pooled prospective cohorts.
Systematic review
HFCS & liver injury systematic review 2025 (Frontiers)
✓ Full text
Systematic review concluded HFCS intake is associated with hepatic steatosis, raised uric acid, and impaired glucose metabolism via fructose-driven de novo lipogenesis, while noting effects largely track with excess intake rather than HFCS being uniquely toxic versus other sugars.
Meta-analysis
Chiavaroli 2025
✓ Full text
Systematic review and meta-analysis of fructose-containing sugars and metabolic risk found HFCS interventions at varying concentrations showed consistent trends toward increased LDL cholesterol (effect sizes 0.209-0.349 mmol/L), though individual comparisons did not reach significance.
Meta-analysis
Pan 2025
✓ PubMed
Dose-response meta-analysis of prospective cohorts (29 cohorts; SSB n=541,288) found each additional daily sugar-sweetened beverage serving raised type 2 diabetes risk by ~25% (RR 1.25), while added sugar and fructose per se showed no association.
Meta-analysis
Le 2022 (Frontiers in Nutrition)
✓ Full text
Systematic review/meta-analysis of 4 trials (9 arms, 767 participants) found HFCS did not significantly differ from sucrose for weight or most metabolic parameters, but raised CRP (+0.27 mg/L, 95% CI 0.02-0.52).
Meta-analysis
Chiu 2022
✓ Full text
Systematic review and meta-analysis of 51 controlled trials (n=2,059) found sugar-sweetened beverages providing excess energy at high doses produced large increases in liver fat and small increases in ALT, implicating fructose-containing SSBs in NAFLD.
Meta-analysis
Liu 2022
✓ Full text
Systematic review and meta-analysis comparing HFCS with sucrose found no significant differences in body weight, waist circumference, BMI or fat mass between the two sweeteners at matched doses.
Guideline
WHO 2023
✓ Source
WHO guideline recommends reducing free sugars (including those in HFCS-sweetened beverages) to under 10% of energy, with a conditional suggestion below 5%, citing weight gain and cardiometabolic risk.
Meta-analysis
Chiu 2014 (Eur J Clin Nutr)
✓ Source
Meta-analysis of controlled feeding trials found fructose in excess (hypercaloric) increased liver fat and ALT, while isocaloric exchange of fructose for other carbohydrate did not — implicating excess calories/fructose in NAFLD markers.
Agency / regulator
FDA 21 CFR 184.1866
✓ Source
FDA affirmed HFCS (42% or 55% fructose) as Generally Recognized As Safe as a direct human food ingredient with no limitation other than current good manufacturing practice.
Observational
de Koning 2012 (HPFS cohort, Malik et al.)
✓ PubMed
Prospective cohort of 42,883 men over 22 years (3,683 CHD cases) found the top vs bottom quartile of sugar-sweetened beverage intake had ~20% higher coronary heart disease risk (RR 1.20).